For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Analytical methods

Common impurities in synthetic peptides

Most synthetic peptides are made by solid-phase synthesis, one amino acid at a time. Each step that doesn't go to completion leaves a predictable kind of impurity, and most of them can be recognised in HPLC and MS data.

Published 18 November 2026

Why impurities are expected

In solid-phase peptide synthesis (SPPS), each amino acid is coupled to a growing chain and then deprotected before the next coupling. Even with coupling efficiencies above 99%, small losses at every step add up over a long sequence. Purification by preparative HPLC removes most by-products, but closely related species can remain. That is why a purity figure always comes with a method.

The main impurity types

ImpurityHow it formsWhat it looks like in the data
Deletion sequencesA coupling step fails, so one residue is missing from an otherwise complete chainMS: mass lower than target by one residue's mass. HPLC: often elutes close to the main peak
Truncated sequencesChains stop growing early (often after capping of unreacted sites)MS: shorter fragments. HPLC: usually well separated from the main peak
Incomplete deprotectionA side-chain protecting group survives the final cleavageMS: mass higher than target by the protecting group's mass
OxidationMethionine (and sometimes tryptophan or cysteine) oxidises during synthesis, handling or storageMS: +16 Da per oxidised methionine. HPLC: typically elutes slightly earlier
RacemisationAn amino acid converts partly to its mirror-image (D) form during couplingMS: same mass as the target, so it is invisible to MS alone. HPLC: may appear as a shoulder or close peak
DeamidationAsparagine or glutamine side chains convert to acidsMS: +1 Da (hard to resolve at low resolution). HPLC: a nearby peak

Reading a COA with impurities in mind

  • A single HPLC purity figure doesn't tell you which impurities are present. A chromatogram, ideally with LC-MS peak assignments, does.
  • Same-mass impurities (racemisation, some isomers) need chromatographic separation; MS identity alone can't exclude them.
  • For sensitive assays, ask whether the main impurities have been identified and at what level.

Related: Peptide purity: HPLC and mass spectrometry explained.

Further reading

Sources and further reading

  • United States Pharmacopeia, General Chapter <1503> Quality Attributes of Synthetic Peptide Drug Substances.
  • ICH Q6B, Specifications for Biotechnological/Biological Products.
  • Standard SPPS references (Fmoc/tBu chemistry) from major peptide-synthesis reagent manufacturers.

Frequently asked questions

Why do synthetic peptides contain impurities?

In solid-phase synthesis each coupling and deprotection step that does not go to completion leaves a predictable by-product, and small losses add up over a long sequence. Preparative HPLC removes most but not all.

How does a deletion sequence show up in the data?

In MS as a mass lower than the target by one residue mass, and in HPLC often as a peak close to the main one.

Which impurities cannot be seen by mass spectrometry alone?

Same-mass impurities such as racemised (D-amino acid) forms and some isomers. They need chromatographic separation.

What does oxidation look like?

About +16 Da per oxidised methionine in MS, and typically a slightly earlier-eluting peak in HPLC.